Team (TISI) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
12 Nov, 2026Executive summary
Q3 revenue fell 2.0% YoY to $220.369M; adjusted EBITDA rose 8.2% to $15.739M, while operating results shifted to a $0.471M loss from $1.342M income.
Transformation and diversification progressed as deferred turnaround work weighed on results; much of the delayed activity is expected to return in early 2027.
Financial highlights
Gross margin was $55.768M, or 25.3% of revenue, versus $58.044M a year earlier; net loss narrowed to $11.068M from $11.447M.
Excluding identified non-core expenses, Q3 operating income was $7.517M versus $5.442M YoY; identified non-core expenses totaled $7.988M.
Adjusted SG&A declined 7.4% to $43.3M, or 19.7% of revenue; reported SG&A was $50.698M versus $51.239M.
Nine-month revenue declined 1.1% to $664.103M; net loss narrowed to $29.213M, while adjusted EBITDA fell to $36.216M from $44.322M.
Q3 diluted loss per share was $3.10 versus $2.68; adjusted net loss was $3.399M, or $1.43 per share.
Outlook and guidance
FY 2026 guidance: revenue $870M–$890M, gross margin $226M–$249M and adjusted EBITDA $56M–$59M; revisions reflect deferred work shifted beyond year-end.
FY 2026 capital expenditure guidance is $13M–$14M; structural cost improvements are targeted at $15M–$18M in 2026 and $30M–$38M at full annual run rate.
Guidance assumes stable Inspection and Heat-Treating activity, no further Middle East escalation and realization of cost actions already taken; 2027 guidance was not issued.
Much deferred turnaround activity is expected to return in early 2027, subject to customer schedules and refining utilization.
Latest events from Team
- Q2 2026 revenue and margins declined, but cost cuts and diversification efforts are in progress.TISI
Q2 2026 - Revenue up 8.3%, Adjusted EBITDA up 45.2%, net loss narrows, and outlook remains strong.TISI
Q1 2026 - 2026 meeting features key votes on directors, compensation, warrants, equity plan, and auditor.TISI
Proxy filing - 2026 meeting covers director elections, compensation, auditor, warrant issuance, and equity plan.TISI
Proxy filing - Revenue, operating income, and adjusted EBITDA rose, margins improved, and debt was reduced.TISI
Q4 2025 - Registering 1.45M shares for resale post-$75M private placement, supporting recapitalization.TISI
Registration Filing - Q3 2024 revenue and margins improved, but guidance was lowered amid ongoing liquidity and NYSE risks.TISI
Q3 2024 - Margins and cash flow improved in Q2 2024, with full-year growth and guidance reaffirmed.TISI
Q2 2024 - Margins and EBITDA improved in 2024, with refinancing extending debt maturities to 2030.TISI
Q4 2024